Longview Partners Guernsey LTD Has $588.78 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Longview Partners Guernsey LTD cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 12.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,832,602 shares of the company’s stock after selling 262,550 shares during the period. HCA Healthcare accounts for about 4.4% of Longview Partners Guernsey LTD’s investment portfolio, making the stock its 12th biggest position. Longview Partners Guernsey LTD owned approximately 0.70% of HCA Healthcare worth $588,778,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. MFA Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $28,000. Bangor Savings Bank increased its holdings in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC boosted its holdings in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares during the last quarter. Finally, LifeSteps Financial Inc. acquired a new stake in shares of HCA Healthcare in the 1st quarter valued at approximately $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $404.37 on Friday. The stock has a 50 day moving average of $370.57 and a 200-day moving average of $340.59. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $405.70. The company has a market capitalization of $105.91 billion, a P/E ratio of 20.16, a P/E/G ratio of 1.46 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter in the previous year, the firm posted $4.29 EPS. HCA Healthcare’s revenue was up 10.3% compared to the same quarter last year. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock valued at $6,407,273 in the last three months. Corporate insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. UBS Group increased their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Robert W. Baird assumed coverage on HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price for the company. Barclays upped their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Finally, Leerink Partners upped their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have given a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $359.89.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.